Demonstrates improved stability in ruthenium oxide, suggesting better performance for energy applications.
Ligand-substitution-mediated crystal engineering minimizes defects in RuO 2 to suppress the LOM and eliminate additional, low-activity and unstable CUS, thereby enhancing stability.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: